Cargando…

Characteristics of Postvaccination Coronavirus Disease 2019 Hospitalizations Prior to Booster Vaccines

This analysis describes clinical characteristics and outcomes of 128 fully vaccinated patients hospitalized with coronavirus disease 2019 (COVID-19) prior to booster vaccines. We found that 27% were asymptomatic, 52% required intensive care, and 15% died from COVID-19. Most (89.2%) fully vaccinated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moffa, Matthew A, Shively, Nathan R, Walsh, Thomas L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903381/ https://www.ncbi.nlm.nih.gov/pubmed/35308487 http://dx.doi.org/10.1093/ofid/ofac014

Ejemplares similares

Description of Hospitalizations due to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Based on Vaccination Status
por: Moffa, Matthew A, et al.
Publicado: (2022)

Clinical Characteristics of COVID-19 Patients' Postvaccination
por: Zhang, Xiao-Bin, et al.
Publicado: (2022)

Postvaccinal Encephalitis after ChAdOx1 nCov‐19
por: Zuhorn, Frédéric, et al.
Publicado: (2021)

Variants of Concern Are Overrepresented Among Postvaccination Breakthrough Infections of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Washington State
por: McEwen, Abbye E, et al.
Publicado: (2021)

Vaccine-Associated Disease Enhancement (VADE): Considerations in Postvaccination COVID-19
por: Tunjungputri, Rahajeng N., et al.
Publicado: (2021)

Clinical Outcomes in Hospitalized Vaccine-Breakthrough Coronavirus Disease 2019 Cases Compared With Contemporary Unvaccinated Hospitalized Adults
por: Wolff, Marcelo, et al.
Publicado: (2022)

Postvaccination Multisystem Inflammatory Syndrome in Adult with No Evidence of Prior SARS-CoV-2 Infection
por: Choi, Young Kyun, et al.
Publicado: (2022)

COVID-19 Vaccines and Hyperglycemia—Is There a Need for Postvaccination Surveillance?
por: Samuel, Samson Mathews, et al.
Publicado: (2022)

Factors Associated With Acceptance of Telehealth-Based Antimicrobial Stewardship Program Recommendations in a Community Hospital Health System
por: Shively, Nathan R, et al.
Publicado: (2022)

Coronavirus disease 2019 vaccine hesitancy among children’s hospital staff: A single-center survey
por: Kociolek, Larry K., et al.
Publicado: (2021)

1655. Factors Associated with Acceptance of Telehealth-based Antimicrobial Stewardship Program Recommendations in a Community Hospital Health System
por: Shively, Nathan R, et al.
Publicado: (2022)

The latent period of coronavirus disease 2019 with SARS‐CoV‐2 B.1.617.2 Delta variant of concern in the postvaccination era
por: Ma, Tao, et al.
Publicado: (2022)

Coronavirus Disease 2019 Vaccine Booster Effects Are Seen in Human Milk Antibody Response
por: Bender, Jeffrey M., et al.
Publicado: (2022)

Axillary Lymphadenopathy After Coronavirus Disease 2019 Vaccinations in Patients With Thoracic Malignancy: Incidence, Predisposing Factors, and Imaging Characteristics
por: Nishino, Mizuki, et al.
Publicado: (2022)

COVID-19 postvaccination adverse events and vaccine hesitancy among hospital employees: Is there a link?
por: Weiland, Anastasiia, et al.
Publicado: (2022)

Dysautonomia in Children with Post-Acute Sequelae of Coronavirus 2019 Disease and/or Vaccination
por: Buchhorn, Reiner
Publicado: (2022)

1087. Fluoroquinolone Prophylaxis vs. No Bacterial Prophylaxis in Hospitalized Neutropenic Patients Undergoing Induction Chemotherapy for Acute Myeloid Leukemia
por: Buchanan, Carley, et al.
Publicado: (2019)

Changes in hospitalized coronavirus disease 2019 (COVID-19) patient characteristics and resource use in a system of community hospitals in the United States
por: Sands, Kenneth E., et al.
Publicado: (2020)

Immunogenicity of SCB-2019 Coronavirus Disease 2019 Vaccine Compared With 4 Approved Vaccines
por: Ambrosino, Donna, et al.
Publicado: (2021)

Correlation of Postvaccination Fever With Specific Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 BNT162b2 Booster and No Significant Influence of Antipyretic Medication
por: Tani, Naoki, et al.
Publicado: (2022)

Regimen of Coronavirus Disease 2019 Vaccination Influences Extent and Kinetics of Antibody Avidity
por: Rössler, Annika, et al.
Publicado: (2022)

Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent Adults
por: Florea, Ana, et al.
Publicado: (2022)

Severe acute respiratory syndrome coronavirus-2 IgG antibody response to coronavirus disease 2019 vaccination in South Indian health-care professionals with and without coronavirus disease 2019 exposure
por: Jayashri, Ramamoorthy, et al.
Publicado: (2022)

Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines
por: Brunner-Ziegler, Sophie, et al.
Publicado: (2022)

Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults
por: Bruxvoort, Katia J, et al.
Publicado: (2021)

Increasing Coronavirus Disease 2019 Vaccine Uptake in Pediatric Primary Care by Offering Vaccine to Household Members
por: Burkhardt, Mary Carol, et al.
Publicado: (2022)

Evaluation of the US Definitions for Coronavirus Disease 2019 Community Risk Levels
por: Mokhtar, Sina, et al.
Publicado: (2022)

Viral Load Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Individuals With Coronavirus Disease 2019
por: Regan, James, et al.
Publicado: (2021)

Plans to Vaccinate Children for Coronavirus Disease 2019: A Survey of United States Parents
por: Teasdale, Chloe A., et al.
Publicado: (2021)

Postvaccine Myocarditis: A Risk Worth the Reward?
por: Raman, Betty, et al.
Publicado: (2022)

Postvaccination Acute Exacerbations of Idiopathic Pulmonary Fibrosis?
por: Huang, Jin-Xian, et al.
Publicado: (2022)

Postvaccine myocarditis and the use of antipyretics: Is there any relation?
por: Fatima, Maurish, et al.
Publicado: (2023)

Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China
por: Wu, Ping, et al.
Publicado: (2020)

Coronavirus Disease 2019 Vaccine Impact on Rates of Severe Acute Respiratory Syndrome Coronavirus 2 Cases and Postvaccination Strain Sequences Among Health Care Workers at an Urban Academic Medical Center: A Prospective Cohort Study
por: Bouton, Tara C, et al.
Publicado: (2021)

mRNA Coronavirus Disease 2019 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study
por: Kohli, Utkarsh, et al.
Publicado: (2022)

Effect of Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Booster on Human Immunodeficiency Virus Reservoirs and Immune Markers
por: Rai, M Ali, et al.
Publicado: (2022)

Coronavirus Disease 2019 Infection in Children with Pre-Existing Heart Disease
por: Simpson, Megan, et al.
Publicado: (2020)

Medically Attended Acute Adverse Events in Pregnant People After Coronavirus Disease 2019 (COVID-19) Booster Vaccination
por: DeSilva, Malini B., et al.
Publicado: (2023)

Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic
por: Rose, Ashley N, et al.
Publicado: (2021)

Acceptability of Vaccines Against Preventable Infections Including Coronavirus Disease 2019 Among Patients With Rheumatic Disease
por: Tedeschi, Sara K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4t49iq85j85t2rjduo5a3q0nmd